Joseph Benesch - Jul 23, 2024 Form 4 Insider Report for Journey Medical Corp (DERM)

Role
CFO
Signature
/s/ Ramsey Alloush, attorney-in-fact
Stock symbol
DERM
Transactions as of
Jul 23, 2024
Transactions value $
-$21,897
Form type
4
Date filed
7/23/2024, 04:01 PM
Previous filing
Feb 23, 2024
Next filing
Aug 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DERM Common Stock, $0.0001 par value Sale -$21.9K -4.06K -6.68% $5.40 56.7K Jul 23, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the vesting of restricted stock units on July 21, 2024, a total of 4,055 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units.
F2 Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 23, 2024, was $5.40 to $5.43. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 Includes restricted stock units, which vest over various time periods.